References

Please note that parts of this guideline may be out of date, an update will be published as soon as it is available.

1. American Psychiatric Association. Practice Guideline for the Treatment of Patients With Major Depressive Disorder, 2nd ed. Am J Psychiatry 2000;157:1-45.
2. Canadian Psychiatric Association. Canadian Network for Mood and Anxiety Treatments (CANMAT). Clinical guidelines for the treatment of depressive disorders. Can J Psychiatry 2001;46 (Suppl 1):5S-90S.3. 
3. National Institute for Health and Clinical Excellence. Depression: the Treatment and Management of Depression in Adults. 2009. http://www.nice.org.uk/CG90. (accessed 6 August 2013).
4. Royal Australian and New Zealand College of Psychiatrists, Clinical Practice Guidelines Team forDepression. Australian and New Zealand Clinical Practice Guidelines for the Treatment of Depression. Aust N Z J Psychiatry 2004;38:389-407.
5. Suehs BT, Argo TR, Bendele SD, et al. Texas Medication Algorithm Project Procedural Manual: Major Depressive Disorder Algorithms. 2008. Austin: Texas Department of State Health Services http://www.dshs.state.tx.us/mhprograms/disclaimer.shtm (accessed August 2013).
6. Bauer M, Bschor T, Pfennig A et al, for the WFSBP Task Force on Unipolar Depressive Disorders.  World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for biological treatment of unipolar depressive disorders in primary care. World Journal of Biological Psychiatry 2007;8:67-104.
7. Anderson IM, Ferrier IN, Baldwin RC, et al. Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines. J Psychopharmacol 2008;22:343-396.[http://dx.doi.org/1177/0269881107088441]
8. Klerman GL, Weissman MM. The course, morbidity, and costs of depression. Arch Gen Psychiatry1992;49:831-834.
9. Mintz J, Mintz LI, Arruda MJ, Hwang SS. Treatments of depression and functional capacity to work. Arch Gen Psychiatry 1992;49:761-768.
10. Judd LL, Akiskal HS, Zeller PJ, et al. Psychosocial disability during the long-term course of unipolar major depressive disorder. Arch Gen Psychiatry 2000;57:375-380.
11. Hirschfeld RM, Montgomery SA, Keller MB, et al. Social functioning in depression: a review. J Clin Psychiatry 2000;61:268-275.
12. Murray CJL, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997;349:1436-1442.
13. Murray CJL, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997;349:1498-1504.
14. Wittchen HU. Epidemiology of affective disorders. In: Helmchen H, Henn F, Lauter H, Sartorius N, eds. Contemporary Psychiatry, Vol. 3. Heidelberg: Springer, 2000:231-241.
15. Regier DA, Narrow WE, Rae DS, et al. The de facto US mental and addictive disorders service system. Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services. Arch Gen Psychiatry 1993;50:85-94.
16. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry 1994;51:8-19.
17. Picinelli M, Gomez Homen F. Gender differences in the epidemiology of affective disorders and schizophrenia. Geneva: World Health Organization, 1997.
18. Williams DR, Herman A, Stein DJ, et al. Twelve-month mental disorders in South Africa: prevalence, service use and demographic correlates in the population-based South African Stress and Health Study. Psychol Med 2008;38:211-220.
19. Angst J, Preisig M. Course of a clinical cohort of unipolar, bipolar and schizoaffective patients. Results of a prospective study from 1959 to 1985. Schweizer Archiv fur Neurologie und Psychiatrie 1995;146:5-16.
20. Maier W, Gaensicke M, Freyberger HJ, et al. Generalized anxiety disorder (ICD-10) in primary care from a cross-cultural perspective: A valid diagnostic entity? Acta Psychiatr Scand 2000;101:29-36.
21. Sullivan PF, Neale MC, Kendler KS. Genetic epidemiology of major depression: Review and meta-analysis. Am J Psychiatry 2000;157:1552-1562.
22. Melartin T, Rytsala H, Leskela U, et al. Current comorbidity of psychiatric disorders among DSM-IV major depressive disorder patients in psychiatric care in the Vantaa Depression Study. J Clin Psychiatry 2002;63:126-134.
23. Zimmerman M, Chelminski I, McDermut W. Major depressive disorder and axis I diagnostic comorbidity. J Clin Psychiatry 2002;63:187-193.
24. Wells KB, Stewart A, Hays RD, et al. The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. JAMA 1989;262:914-919.
25. Agency for Health Care Policy and Research (AHCPR). Evidence Report on Treatment of Depression: Newer Pharmacotherapies. San Antonio Evidence-Based Practice Center. Washington, DC: AHCPR, Evidence-Based Practice Centers, 1999, AHCPR pub. No. 99-E014.
26. Unützer J, Patrick DL, Diehr P, et al. Quality adjusted life years in older adults with depressive symptoms and chronic medical disorders. Int Psychogeriatr 2000;12:15-33.
27. Rihmer Z. Suicide and bipolar disorder. In: Zarate CA, Manji HK, eds. Bipolar Depression: MolecularNeurobiology, Clinical Diagnosis and Pharmacotherapy. Basel: Birkhauser Verlag, 2009:47-56.
28. Angst J. Suicide risk in patients with major depressive disorder. J Clin Psychiatry 1999;60 (Suppl 2):57-62.
29. Bostwick JM, Pankratz VS. Affective disorders and suicide risk: A reexamination. Am J Psychiatry 2000;157:1925-1932.
30. Wulsin LR, Vaillant GE, Wells VE. A systematic review of the mortality of depression. Psychosom Med1999;61:6-17.
31. Brunello N, Burrows GD, Jönsson CPB, et al. Critical issues in the treatment of affective disorders. Depression 1995;3:187-198.
32. Booth BM, Zang M, Rost KM, et al. Measuring outcomes and costs for major depression. Psychopharmacology Bulletin 1997;33:653-658.
33. Wells KB, Hays RD, Burnam MA, etal. Detection of depressive disorder for patients receiving prepaid or fee-for service care. Results from the Medical Outcomes Study. JAMA 1989;262:3298-3302.
34. Üstün TB, Sartorius N. Mental Illness in General Health Care: An International Study. Chichester: Wiley, 1995.
35. Unützer J, Simon G, Belin TR, et al. Care for depression in HMO patients aged 65 and older. J Am Geriatr Soc 2000;48:871-878.
36. Young AS, Klap R, Sherbourne CD, Wells KB. The quality of care for depressive and anxiety disorders in the United States. Arch Gen Psychiatry 2001;58:55-61.
37. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR). Washington, DC: American Psychiatric Association, 2000.
38. World Health Organization. Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death, Tenth Revision. Geneva: World Health Organization, 1992.
39. Solomon DA, Keller MB, Leon AC, et al. Recovery from major depression. A10-year prospective follow-up across multiple episodes. Arch Gen Psychiatry 1997;54:1001-1006.
40. Keller MB, Lavori PW, Rice J, et al. The persistent risk of chronicity in recurrent episodes of non bipolar major depressive disorder: A prospective follow up. Am J Psychiatry 1986;143:24-28.
41. Mueller TI, Leon AC, Keller MB, et al. Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. Am J Psychiatry 1999;156:1000-1006.
42. Angst J. Major depression in 1998: Are we providing optimal therapy? J Clin Psychiatry 1999:60(Suppl 6):5-9.
43. Judd LL, Akiskal HS, Maser JD, et al. A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Arch Gen Psychiatry 1998;55:694-700.
44. Judd LL, Paulus MJ, Schettler PJ, et al. Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness? Am J Psychiatry 2000;157:1501-1504.
45. AngstJ.The course of affective disorders. Psychopathology 1986;19(Suppl 2):47-52.
46. Scott J.Chronic depression. Br J Psychiatry 1988;153:287-297.
47. Paykel ES. Epidemiology of refractory depression. In: Nolen WA, Zohar J, Roose SP, Amsterdam JD, eds. Refractory Depression: Current Strategies and Future Directions. Chichester: Wiley,1994:3-17.
48. Gelenberg AJ. Using assessment tools to screen for, diagnose, and treat major depressive disorder in clinical practice. J Clin Psychiatry 2010;71(Suppl E 1):e01. [http://dx.doi.org/10.4088/JCP.9058se1c.01gry]
49. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical interview for DSM-IV-TRAxis I disorders, Research Version, Non-patient Edition (SCID-I/NP). New York: BiometricsResearch, New York State Psychiatric Institute, 2002.
50. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(Suppl 20):22-33.
51. Kroenke K, Spitzer R, et al. The PHQ-9: Validity of a brief depression symptom severity measure. J Gen Intern Med 2001;16:606-613.
52. Spitzer RL, Williams JBW, Kroenke K, et al. Utility of a new procedure for diagnosing mental disorders in primary care: the PRIME-MD 1000 Study. JAMA 1994;272:1749-1756.
53. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
54. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-389.
55. Rush AJ, Trivedi MH, Ibrahim HM, et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): A psychometric evaluation in patients with chronic major depression. Biol Psychiatry 2003;54:573-583.
56. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571.
57. O’Donovan C. Achieving and sustaining remission in depression and anxiety disorders: Introduction. Can J Psychiatry 2004;49 (Suppl 1):5S-9S.
58. Judd L, Schettler P, Akiskal H. The prevalence, clinical relevance, and public health significance of subthreshold depressions. Psychiatr Clin North Am 2002;25:685-698.
59. Parikh S, Lam R. Clinical guidelines for the treatment of depressive disorders, I. Definitions, prevalence, and health burden. Can J Psychiatry 2001;46(Suppl 1):13S-20S.
60. National Institute of Mental Health. Sequenced Treatment Alternatives to Relieve Depression.2002. Bethesda, MD: National Institute of Mental Health, 2002. http://www.edc.gsph.pitt.edu/stard/public/index.html-ssi.
61. Nutt D. Treatment of depression and concomitant anxiety. Eur Neuropsychopharmacol 2000;10(Suppl 4):S433-437.
62. Davidson JRT. Major depressive disorder treatment guidelines in America and Europe. J Clin Psychiatry 2010;71(Suppl E):e04.
63. Anderson IM, Nutt DJ, Deakin JF. Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 1993 British Association for Psychopharmacology Guidelines. J Psychopharmacol 2000;14:3-20.
64. Baldwin R, Wild R. Management of depression in later life. Advances in Psychiatric Treatment 2004;10:131-139. [http://dx.doi.org/10.1192/apt.10.2.131]
65. Nutt DJ, Davidson JR, Gelenberg AJ, et al. International consensus statement on major depressive disorder. J Clin Psychiatry 2010;71(Suppl E1):e08. [http://dx.doi.org/10.4088/JCP.9058se1c.08gry]
66. Birkenhager TK, Moleman P, Nolen WA. Benzodiazepines for depression? A review of the literature. Int Clin Psychopharmacol 1995;10:181-195.
67. Nemeroff CB, Heim CM, Thase ME, et al. Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma. Proc Natl Acad Sci U S A 2003;100:14293-14296.
68. Pae C-U, Tharwani H, Marks DM, et al. Atypical Depression: A Comprehensive Review. CNS Drugs 2009;23:1023-1037.
69. Westrin A, Lam RW. Seasonal affective disorder: A clinical update. Ann Clin Psychiatry 2007;19:239-246.
70. Young JL, Rund D. Psychiatric considerations in patients with decreased levels of consciousness. Emerg Med Clin North Am 2010;28:595-609.
71. Bush G, Fink M, Petrides G, et al. Catatonia II. Treatment with lorazepam and electroconvulsive therapy. Acta Psychiatr Scand 1996;93:137-143.
72. Montgomery Sa, Judge R. Treatment of depression with associated anxiety: Comparisons of tricyclic antidepressants and selective serotonin reuptake inhibitors. Acta Psychiatr Scand 2000;403:9-16.
73. Schneier FR, Blanco C, Campeas R, et al. Citalopram treatment of social anxiety disorder with comorbid major depression. Depress Anxiety 2003;17:191-196.
74. Jefferson JW. Social Anxiety Disorder: More than just a little shyness. Primary Care Companion to J Clin Psychiatry 2001;3:4-9.
75. American Psychiatric Association. Practice guideline for the treatment of patients with borderline personality disorder. Am J Psychiatry 2001;158:1-52.
76. Levenson JL. Depression in the medically ill. Primary Psychiatry 2005;12:22-24.
77. Yanofski J, Croarkin P. Choosing antidepressants for HIV and AIDS patients: Insights on safety and side effects. Psychiatry 2008;5:61-66.
78. Teicher MH, Glod CA, Cole JO. Antidepressant drugs and the emergence of suicidal tendencies. Drug Safety 1993;8:186-212.
79. Hammad TA. Review and evaluation of clinical data. Washington, DC: Food and Drug Administration, 2004. http://www.fda.gov/ohrms/dockets/ac/04/briefing/2004-4065b1-10-TAB08-Hammads-Review.pdf.
80. Hammad TA, Laughren T, Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry 2006;63:332-339.
81. Gibbons RD, Brown CH, Hur K, et al. Relationship between antidepressants and suicide attempts: An analysis of the veterans health administration data sets. Am J Psychiatry 2007;164:1044-1049.
82. Kalra S, Born L, Sarkar M, Einarson A. The safety of antidepressant use in pregnancy. Exp Opin Drug Saf 2005;4:273-284.
83. Eberhard-Gran M, Eskild A, Opjordsmoen S. Treating mood disorders during pregnancy: Safety considerations. Drug Saf 2005;28:695-706.
84. Chambers CD, Hernandez-Diaz S, Van Marter LJ, et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. New Engl J Med 2006;354:579-587.
85. Wisner KL, Parry BL, Piontek CM. Postpartum depression. New Engl J Med 2002;347:194-199.86. Kohen D. Psychotropic medication and breast-feeding. Advances in Psychiatric Treatment 2005;11:371-379.
86. Hirschfeld RMA, Montgomery SA, Aguglia E, et al. Partial response and nonresponse to antidepressant therapy: Current approaches and treatment options. J Clin Psychiatry 2002;63:826-837.
87. Fava M, Rush AJ. Current status of augmentation and combination treatments for major depressive disorder: A literature review and a proposal for a novel approach to improve practice. Psychother Psychosom 2006;75:139-153.